EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Evolving roles of activins and inhibins in ovarian cancer pathophysiology

Elizabeth T Evans, Ben Horst, Rebecca C Arend, Karthikeyan Mythreye iD

American Journal of Physiology-Cell Physiology · 2023

DOI: 10.1152/ajpcell.00178.2022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Elizabeth T Evans und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Heersink School of Medicine, University of Alabama School of Medicine, Birmingham, Alabama. Hauptthemen laut MEDLINE: Inhibins, Ovarian Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activins and inhibins are unique members of the transforming growth factor-β (TGFβ) family of growth factors, with the ability to exert autocrine, endocrine, and paracrine effects in a wide range of complex physiologic and pathologic processes. Although first isolated within the pituitary, emerging evidence suggests broader influence beyond reproductive development and function. Known roles of activin and inhibin in angiogenesis and immunity along with correlations between gene expression and cancer prognosis suggest potential roles in tumorigenesis. Here, we present a review of the current understanding of the biological role of activins and inhibins as it relates to ovarian cancers, summarizing the underlying signaling mechanisms and physiologic influence, followed by detailing their roles in cancer progression, diagnosis, and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InhibinsOvarian NeoplasmsHumansFemaleActivinsSignal TransductionEndocrine System

Stichwörter der Autor:innen

TGFβ superfamilyactivininhibinovarian cancertumor immune environment

Substanzen

InhibinsActivins

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Heersink School of Medicine, University of Alabama School of Medicine, Birmingham, Alabama.
  • Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

ORCID-Profile: Karthikeyan Mythreye

Förderung

  • NCI NIH HHS
  • HHS | NIH | National Cancer Institute

Zitieren

APA

Evans, E. T., Horst, B., Arend, R. C., & Mythreye, K. (2023). Evolving roles of activins and inhibins in ovarian cancer pathophysiology. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00178.2022

Vancouver

Evans ET, Horst B, Arend RC, Mythreye K. Evolving roles of activins and inhibins in ovarian cancer pathophysiology. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00178.2022

BibTeX
@article{Evans2023,
  author = {Evans, Elizabeth T and Horst, Ben and Arend, Rebecca C and Mythreye, Karthikeyan},
  title = {Evolving roles of activins and inhibins in ovarian cancer pathophysiology},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2023},
  doi = {10.1152/ajpcell.00178.2022}
}
Kostenlos starten →